Glycosaminoglycan (GAG) biosynthesis and GAG-binding proteins

Progress in Molecular Biology and Translational Science

Volumn 93, Issue C, 2010, Pages 1-17

  Zhang, Lijuan ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Biosynthesis; Chondroitin sulfate; GAG binding proteins; Glycosaminoglycan (GAG); Heparan sulfate; Sulfotransferase

Indexed keywords

CARRIER PROTEIN; GLYCOSAMINOGLYCAN;

ANIMAL; BIOSYNTHESIS; HUMAN; METABOLISM; REVIEW;

ANIMALS; CARRIER PROTEINS; GLYCOSAMINOGLYCANS; HUMANS;

EID: 77958189486     PISSN: 18771173     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S1877-1173(10)93001-9     Document Type: Chapter

References (102)

1. J.D. Esko, and S.B. Selleck Order out of chaos: assembly of ligand binding sites in heparan sulfate Annu Rev Biochem 71 2002 435 471
2. J.E. Silbert, and G. Sugumaran Biosynthesis of chondroitin/dermatan sulfate IUBMB Life 54 2002 177 186
3. A.D. Lander, and S.B. Selleck The elusive functions of proteoglycans: in vivo veritas J Cell Biol 148 2000 227 232
4. P. Marynen, J. Zhang, J.J. Cassiman, H. Van den Berghe, and G. David Partial primary structure of the 48- and 90-kilodalton core proteins of cell surface-associated heparan sulfate proteoglycans of lung fibroblasts. Prediction of an integral membrane domain and evidence for multiple distinct core proteins at the cell surface of human lung fibroblasts J Biol Chem 264 1989 7017 7024
5. G. David, and H. Van den Berghe Cell-surface heparan sulfate and heparan-sulfate/chondroitin-sulfate hybrid proteoglycans of mouse mammary epithelial cells Eur J Biochem 178 1989 609 617
6. G. David, V. Lories, B. Decock, P. Marynen, J.J. Cassiman, and H. Van den Berghe Molecular cloning of a phosphatidylinositol-anchored membrane heparan sulfate proteoglycan from human lung fibroblasts J Cell Biol 111 1990 3165 3176
7. G. David, B. van der Schueren, P. Marynen, J.J. Cassiman, and H. van den Berghe Molecular cloning of amphiglycan, a novel integral membrane heparan sulfate proteoglycan expressed by epithelial and fibroblastic cells J Cell Biol 118 1992 961 969
8. V. Lories, J.J. Cassiman, H. Van den Berghe, and G. David Differential expression of cell surface heparan sulfate proteoglycans in human mammary epithelial cells and lung fibroblasts J Biol Chem 267 1992 1116 1122
9. A. Heremans, J.J. Cassiman, H. Van den Berghe, and G. David Heparan sulfate proteoglycan from the extracellular matrix of human lung fibroblasts. Isolation, purification, and core protein characterization J Biol Chem 263 1988 4731 4739
10. K.G. Vogel, and D.W. Peterson Extracellular, surface, and intracellular proteoglycans produced by human embryo lung fibroblasts in culture (IMR-90) J Biol Chem 256 1981 13235 13242
11. U. Hartmann, and P. Maurer Proteoglycans in the nervous systemthe quest for functional roles in vivo Matrix Biol 20 2001 23 35
12. I. Vlodavsky, and Y. Friedmann Molecular properties and involvement of heparanase in cancer metastasis and angiogenesis J Clin Invest 108 2001 341 347 (Pubitemid 32730777)
13. M. Morimoto-Tomita, K. Uchimura, Z. Werb, S. Hemmerich, and S.D. Rosen Cloning and Characterization of Two Extracellular Heparin-degrading Endosulfatases in Mice and Humans J Biol Chem 277 2002 49175 49185
14. G.K. Dhoot, M.K. Gustafsson, X. Ai, W. Sun, D.M. Standiford, and C.P. Emerson Jr Regulation of Wnt signaling and embryo patterning by an extracellular sulfatase Science 293 2001 1663 1666
15. M.A. Kosir, C.C. Quinn, W. Wang, and G. Tromp Matrix glycosaminoglycans in the growth phase of fibroblasts: more of the story in wound healing J Surg Res 92 2000 45 52
16. M. Mack, J. Pfirstinger, C. Weber, K.S. Weber, P.J. Nelson, and T. Rupp Chondroitin sulfate A released from platelets blocks RANTES presentation on cell surfaces and RANTES-dependent firm adhesion of leukocytes Eur J Immunol 32 2002 1012 1020
17. M. Piepkorn, P. Hovingh, and A. Linker Evidence for independent metabolism and cell surface localization of cell surface localization of cellular proteoglycans and glycosaminoglycan free chains J Cell Physiol 135 1988 189 199
18. M. Piepkorn, P. Hovingh, and A. Linker Glycosaminoglycan free chains. External plasma membrane components distinct from the membrane proteoglycans J Biol Chem 264 1989 8662 8669
19. L. Zhang, and J.D. Esko Amino acid determinants that drive heparan sulfate assembly in a proteoglycan J Biol Chem 269 1994 19295 19299
20. L. Zhang, G. David, and J.D. Esko Repetitive Ser-Gly sequences enhance heparan sulfate assembly in proteoglycans J Biol Chem 270 1995 27127 27135
21. L. Zhang, and J.D. Esko Accumulation of a pentasaccharide terminating in alpha-N- acetylglucosamine in an animal cell mutant defective in heparan sulfate biosynthesis J Biol Chem 270 1995 12557 12562
22. J.D. Esko, and L. Zhang Influence of core protein sequence on glycosaminoglycan assembly Curr Opin Struct Biol 6 1996 663 670
23. R.L. Chen, and A.D. Lander Mechanisms underlying preferential assembly of heparan sulfate on glypican-1 J Biol Chem 276 2001 7507 7517
24. P. Govindraj, L. West, T.J. Koob, P. Neame, K. Doege, and J.R. Hassell Isolation and identification of the major heparan sulfate proteoglycans in the developing bovine rib growth plate J Biol Chem 277 2002 19461 19469
25. H. Kresse, D.G. Seidler, M. Muller, E. Breuer, H. Hausser, and P.J. Roughley Different usage of the glycosaminoglycan attachment sites of biglycan J Biol Chem 276 2001 13411 13416
26. C. McCormick, Y. Leduc, D. Martindale, K. Mattison, L.E. Esford, and A.P. Dyer The putative tumour suppressor EXT1 alters the expression of cell-surface heparan sulfate Nat Genet 19 1998 158 161
27. T. Lind, F. Tufaro, C. McCormick, U. Lindahl, and K. Lidholt The putative tumor suppressors EXT1 and EXT2 are glycosyltransferases required for the biosynthesis of heparan sulfate J Biol Chem 273 1998 26265 26268
28. L. Zhang, R. Lawrence, J.J. Schwartz, X. Bai, G. Wei, and J.D. Esko The effect of precursor structures on the action of 3-OST-1 and the biosynthesis of anticoagulant heparan sulfate J Biol Chem 24 2001 24
29. D. Shukla, J. Liu, P. Blaiklock, N.W. Shworak, X. Bai, and J.D. Esko A novel role for 3-O-sulfated heparan sulfate in herpes simplex virus 1 entry Cell 99 1999 13 22
30. J. Liu, Z. Shriver, R.M. Pope, S.C. Thorp, M.B. Duncan, and R.J. Copeland Characterization of a heparan sulfate octasaccharide that binds to herpes simplex virus type 1 glycoprotein D J Biol Chem 277 2002 33456 33467
31. G. Xia, J. Chen, V. Tiwari, W. Ju, J.P. Li, and A. Malmstrom Heparan sulfate 3-O-sulfotransferase isoform 5 generates both an antithrombin-binding site and an entry receptor for herpes simplex virus, type 1 J Biol Chem 277 2002 37912 37919
32. K. Sugahara, Y. Tanaka, S. Yamada, N. Seno, H. Kitagawa, and S.M. Haslam Novel sulfated oligosaccharides containing 3-O-sulfated glucuronic acid from king crab cartilage chondroitin sulfate K. Unexpected degradation by chondroitinase ABC J Biol Chem 271 1996 26745 26754
33. A. Kinoshita, S. Yamada, S.M. Haslam, H.R. Morris, A. Dell, and K. Sugahara Novel tetrasaccharides isolated from squid cartilage chondroitin sulfate E contain unusual sulfated disaccharide units GlcA(3-O-sulfate)beta1- 3GalNAc(6-O-sulfate) or GlcA(3-O-sulfate)beta1-3GalNAc J Biol Chem 272 1997 19656 19665
34. M. Maccarana, S. Kalamajski, M. Kongsgaard, S.P. Magnusson, A. Oldberg, and A. Malmstrom Dermatan sulfate epimerase 1-deficient mice have reduced content and changed distribution of iduronic acids in dermatan sulfate and an altered collagen structure in skin Mol Cell Biol 29 2009 5517 5528
35. R.D. Rosenberg, N.W. Shworak, J. Liu, J.J. Schwartz, and L. Zhang Heparan sulfate proteoglycans of the cardiovascular system. Specific structures emerge but how is synthesis regulated? J Clin Invest 100 1997 S67 S75
36. J.D. Esko, and U. Lindahl Molecular diversity of heparan sulfate J Clin Invest 108 2001 169 173
37. N. Perrimon, and M. Bernfield Specificities of heparan sulphate proteoglycans in developmental processes Nature 404 2000 725 728
38. S.B. Selleck Proteoglycans and pattern formation: sugar biochemistry meets developmental genetics Trends Genet 16 2000 206 212
39. U. Lindahl What else can 'Heparin' do? Haemostasis 29 Suppl. S1 1999 38 47
40. O. Reizes, J. Lincecum, Z. Wang, O. Goldberger, L. Huang, and M. Kaksonen Transgenic expression of syndecan-1 uncovers a physiological control of feeding behavior by syndecan-3 Cell 106 2001 105 116
41. R.V. Iozzo Heparan sulfate proteoglycans: intricate molecules with intriguing functions J Clin Invest 108 2001 165 167
42. R.V. Iozzo, and J.D. San Antonio Heparan sulfate proteoglycans: heavy hitters in the angiogenesis arena J Clin Invest 108 2001 349 355
43. A. Saito, and H. Munakata Analysis of plasma proteins that bind to glycosaminoglycans Biochim Biophys Acta 1770 2007 241 246
44. L. Zhang Amino acid sequences that regulate heparan sulfate biosynthesis L. Zhang, Biochemistry and molecular genetics 1995 University of Alabama at Birmingham Birmingham 201
45. R.U. Margolis, and R.K. Margolis Chondroitin sulfate proteoglycans as mediators of axon growth and pathfinding Cell Tissue Res 290 1997 343 348
46. M. Inatani, M. Honjo, Y. Otori, A. Oohira, N. Kido, and Y. Tano Inhibitory effects of neurocan and phosphacan on neurite outgrowth from retinal ganglion cells in culture Invest Ophthalmol Vis Sci 42 2001 1930 1938
47. S.F. Penc, B. Pomahac, T. Winkler, R.A. Dorschner, E. Eriksson, and M. Herndon Dermatan sulfate released after injury is a potent promoter of fibroblast growth factor-2 function J Biol Chem 273 1998 28116 28121
48. S.F. Penc, B. Pomahac, E. Eriksson, M. Detmar, and R.L. Gallo Dermatan sulfate activates nuclear factor-kappab and induces endothelial and circulating intercellular adhesion molecule-1 J Clin Invest 103 1999 1329 1335
49. T. Renne, and W. Muller-Esterl Cell surface-associated chondroitin sulfate proteoglycans bind contact phase factor H-kininogen FEBS Lett 500 2001 36 40
50. M.M. Maimone, and D.M. Tollefsen Structure of a dermatan sulfate hexasaccharide that binds to heparin cofactor II with high affinity J Biol Chem 265 1990 18263 18271
51. M. Kaplan, and M. Aviram Macrophage plasma membrane chondroitin sulfate proteoglycan binds oxidized low-density lipoprotein Atherosclerosis 149 2000 5 17
52. H.E. Conrad Heparin-binding proteins 1998 Academic Press San Diego
53. L.M. McDowell, B.A. Frazier, D.R. Studelska, K. Giljum, J. Chen, and J. Liu Inhibition or activation of Apert syndrome FGFR2 (S252W) signaling by specific glycosaminoglycans J Biol Chem 281 2006 6924 6930
54. R.H. Schwall, L.Y. Chang, P.J. Godowski, D.W. Kahn, K.J. Hillan, and K.D. Bauer Heparin induces dimerization and confers proliferative activity onto the hepatocyte growth factor antagonists NK1 and NK2 J Cell Biol 133 1996 709 718
55. T.F. Zioncheck, L. Richardson, J. Liu, L. Chang, K.L. King, and G.L. Bennett Sulfated oligosaccharides promote hepatocyte growth factor association and govern its mitogenic activity J Biol Chem 270 1995 16871 16878
56. M. Lyon, J.A. Deakin, H. Rahmoune, D.G. Fernig, T. Nakamura, and J.T. Gallagher Hepatocyte growth factor/scatter factor binds with high affinity to dermatan sulfate J Biol Chem 273 1998 271 278
57. M. Lyon, J.A. Deakin, D. Lietha, E. Gherardi, and J.T. Gallagher The interactions of hepatocyte growth factor/scatter factor and its NK1 and NK2 variants with glycosaminoglycans using a modified gel mobility shift assay: elucidation of the minimal size of binding and activatory oligosaccharides J Biol Chem 279 2004 43560 43567
58. M.W. Barnett, C.E. Fisher, G. Perona-Wright, and J.A. Davies Signalling by glial cell line-derived neurotrophic factor (GDNF) requires heparan sulphate glycosaminoglycan J Cell Sci 115 2002 4495 4503
59. J.A. Davies, E.A. Yates, and J.E. Turnbull Structural determinants of heparan sulphate modulation of GDNF signalling Growth Factors 21 2003 109 119
60. S. Ashikari-Hada, H. Habuchi, Y. Kariya, and K. Kimata Heparin regulates vascular endothelial growth factor165-dependent mitogenic activity, tube formation, and its receptor phosphorylation of human endothelial cells: comparison of the effects of heparin and modified heparins J Biol Chem 280 2005 31508 31515
61. A.M. Dougher, H. Wasserstrom, L. Torley, L. Shridaran, P. Westdock, and R.E. Hileman Identification of a heparin binding peptide on the extracellular domain of the KDR VEGF receptor Growth Factors 14 1997 257 268
62. C. Rolny, D. Spillmann, U. Lindahl, and L. Claesson-Welsh Heparin amplifies platelet-derived growth factor (PDGF)-BB-induced PDGF alpha -receptor but not PDGF beta -receptor tyrosine phosphorylation in heparan sulfate-deficient cells. Effects on signal transduction and biological responses J Biol Chem 277 2002 19315 19321
63. D. Bischof, S.F. Elsawa, G. Mantchev, J. Yoon, G.E. Michels, and A. Nilson Selective activation of TACI by syndecan-2 Blood 2005 2005-2001-0256
64. R. Ruppert, E. Hoffmann, and W. Sebald Human bone morphogenetic protein 2 contains a heparin-binding site which modifies its biological activity Eur J Biochem 237 1996 295 302
65. J.B. Rubin, Y. Choi, and R.A. Segal Cerebellar proteoglycans regulate sonic hedgehog responses during development Development 129 2002 2223 2232
66. W.L. Duvall Antithrombotic therapy Curr Mol Med 6 2006 603 619
67. S.A. Mousa Role of current and emerging antithrombotics in thrombosis and cancer Timely Top Med Cardiovasc Dis 10 2006 E19
68. M. Bartnik, A. Norhammar, and L. Ryden Hyperglycaemia and cardiovascular disease J Intern Med 262 2007 145 156
69. A. Grand'Maison, A.F. Charest, and W.H. Geerts Anticoagulant use in patients with chronic renal impairment Am J Cardiovasc Drugs 5 2005 291 305
70. J.J. Swigris, A. Fischer, J. Gillis, R.T. Meehan, and K.K. Brown Pulmonary and thrombotic manifestations of systemic lupus erythematosus Chest 133 2008 271 280
71. L. Linkins, and T.E. Warkentin The approach to heparin-induced thrombocytopenia Semin Respir Crit Care Med 1 2008 66 74
72. N.S. Jenny, R.L. Lundblad, and K.G. Mann Thrombin R.W. Colman, Hemostasis and thrombosis 2006 Lippincott Williams & Wilkins Philadelphia 193 213
73. E.S. Mullins, K.W. Kombrinck, K.E. Talmage, M.A. Shaw, D.P. Witte, and J.M. Ullman Genetic elimination of prothrombin in adult mice is not compatible with survival and results in spontaneous hemorrhagic events in both heart and brain Blood 113 2009 696 704
74. J. Pan, Y. Qi, X. Zhou, H. Lu, E. Ramacciotti, and L. Zhang Chemically oversulfated glycosaminoglycans are potent modulators of contact system activation and different cell signaling pathways J Biol Chem 2010 10.1074/jbc.M109.063735
75. J. Pan, Y. Qian, X. Zhou, A. Pazandak, S.B. Frazier, and P. Weiser Oversulfated chondroitin sulfate is not the sole contaminant in heparin Nat Biotech 28 2010 203 207
76. J. Pan, Y. Qian, X. Zhou, A. Pazandak, S.B. Frazier, and P. Weiser Identification of chemically sulfated/desulfated glycosaminoglycans in contaminated heparins and development of a simple assay for the detection of most contaminants in heparin Glycobiol. Insight 2 2010 1 12
77. T.K. Kishimoto, K. Viswanathan, T. Ganguly, S. Elankumaran, S. Smith, and K. Pelzer Contaminated heparin associated with adverse clinical events and activation of the contact system N Engl J Med 358 2008 2457 2467 (Pubitemid 351793019)
78. B.A. Waaler Contact activation in the intrinsic blood clotting system; studies on a plasma product formed on contact with glass and similar surfaces Scand J Clin Lab Invest 11 1959 1 133
79. C. Adiguzel, V. Bansal, E. Litinas, J. Cunanan, O. Iqbal, and K. Nelson Increased prevalence of antiheparin platelet factor 4 antibodies in patients may be due to contaminated heparin Clin Appl Thromb Hemost 15 2009 145 151
80. A. Greinacher, and T.E. Warkentin Contaminated heparin N Engl J Med 359 2008 1291 1292 author reply 1293
81. Y. Qian, J. Pan, X. Zhou, P. Weiser, D. Hourcade, K.M. Lizsewski, J.P. Atkinson, H. Lu, and L. Zhang Oversulfated heparin byproducts induce thrombin generation through contact system activation Clin Appl Thromb Hemost 16 2010 244 250
82. Y. Qian, J. Pan, X. Zhou, P. Weiser, H. Lu, F.F. Shih, R. Porche-Sorbet, C. Eby, and L. Zhang Heparin and oversulfated heparin byproduct induce thrombin generation through contact system activation in plasma of patients with HIT Clin Appl Thromb Hemost 16 2010 251 260
83. A. Clark, A. Weymann, E. Hartman, Y. Turmelle, M. Carroll, and J.M. Thurman Evidence for non-traditional activation of complement factor C3 during murine liver regeneration Mol Immunol 45 2008 3125 3132
84. R.W. Colman Contact activation (kallikrein-kinin) pathway: multiple physiologic and pathophysiologic activities R.W. Colman, Hemostasis and thrombosis 2006 Lippincott Williams & Wilkins Philadelphia 107 130
85. M. Huber-Lang, J.V. Sarma, F.S. Zetoune, D. Rittirsch, T.A. Neff, and S.R. McGuire Generation of C5a in the absence of C3: a new complement activation pathway Nat Med 12 2006 682 687
86. C. Maas, J.W. Govers-Riemslag, B. Bouma, B. Schiks, B.P. Hazenberg, and H.M. Lokhorst Misfolded proteins activate Factor XII in humans, leading to kallikrein formation without initiating coagulation J Clin Invest 118 2008 3208 3218
87. R.G. Warner, C. Hundt, S. Weiss, and J.E. Turnbull Identification of the heparan sulfate binding sites in the cellular prion protein J Biol Chem 277 2002 18421 18430
88. S. Supattapone Prion protein conversion in vitro J Mol Med 82 2004 348 356
89. M. Yanagishita, and V.C. Hascall Cell surface heparan sulfate proteoglycans J Biol Chem 267 1992 9451 9454
90. R.D. Sanderson, J.E. Turnbull, J.T. Gallagher, and A.D. Lander Fine structure of heparan sulfate regulates syndecan-1 function and cell behavior J Biol Chem 269 1994 13100 13106
91. N.W. Shworak, T. Kojima, and R.D. Rosenberg Isolation and characterization of ryudocan and syndecan heparan sulfate proteoglycans, core proteins, and cDNAs from a rat endothelial cell line Haemostasis 23 Suppl 1 1993 161 176
92. M.H. Kuehn, and G.S. Hageman Molecular characterization and genomic mapping of human IPM 200, a second member of a novel family of proteoglycans Mol Cell Biol Res Commun 2 1999 103 110
93. S. Acharya, V.C. Foletta, J.W. Lee, M.E. Rayborn, I.R. Rodriguez, and W.S. Young 3rd SPACRCAN, a novel human interphotoreceptor matrix hyaluronan-binding proteoglycan synthesized by photoreceptors and pinealocytes J Biol Chem 275 2000 6945 6955
94. D.J. Wassenhove-McCarthy, and K.J. McCarthy Molecular characterization of a novel basement membrane-associated proteoglycan, leprecan J Biol Chem 274 1999 25004 25017
95. T. Sasaki, K. Mann, and R. Timpl Modification of the laminin alpha 4 chain by chondroitin sulfate attachment to its N-terminal domain FEBS Lett 505 2001 173 178
96. G. Pluschke, M. Vanek, A. Evans, T. Dittmar, P. Schmid, and P. Itin Molecular cloning of a human melanoma-associated chondroitin sulfate proteoglycan Proc Natl Acad Sci USA 93 1996 9710 9715
97. S. Ikegawa, M. Sano, Y. Koshizuka, and Y. Nakamura Isolation, characterization and mapping of the mouse and human PRG4 (proteoglycan 4) genes Cytogenet Cell Genet 90 2000 291 297
98. C. Sassetti, A. Van Zante, and S.D. Rosen Identification of endoglycan, a member of the CD34/podocalyxin family of sialomucins J Biol Chem 275 2000 9001 9010
99. D. Bechard, T. Gentina, M. Delehedde, A. Scherpereel, M. Lyon, and M. Aumercier Endocan is a novel chondroitin sulfate/dermatan sulfate proteoglycan that promotes hepatocyte growth factor/scatter factor mitogenic activity J Biol Chem 276 2001 48341 48349
100. R.R. Wu, and J.R. Couchman cDNA cloning of the basement membrane chondroitin sulfate proteoglycan core protein, bamacan: a five domain structure including coiled-coil motifs J Cell Biol 136 1997 433 444
101. B.T. Kim, K. Tsuchida, J. Lincecum, H. Kitagawa, M. Bernfield, and K. Sugahara Identification and characterization of three Drosophila melanogaster glucuronyltransferases responsible for the synthesis of the conserved glycosaminoglycan-protein linkage region of proteoglycans. Two novel homologs exhibit broad specificity towards oligosaccharides from proteoglycans, glycoproteins and glycosphingolipids J Biol Chem 278 2003 9116 9124
102. H.G. Kang, M.R. Evers, G. Xia, J.U. Baenziger, and M. Schachner Molecular cloning and expression of an N-acetylgalactosamine-4-O- sulfotransferase that transfers sulfate to terminal and non-terminal beta1, 4-linked N-acetylgalactosamine J Biol Chem 3 2001 3